)
Visual
test
Astellas Pharma
Astellas Pharma (4503) investor relations material
Astellas Pharma Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary26 Feb, 2026
Vision and approach to sustainability
Focus on transforming innovative science into value for patients by balancing outcomes and healthcare costs.
Sustainability strategy centers on contributing to society through core business and creating a positive cycle for both company and societal sustainability.
Updated materiality matrix to prioritize nine key sustainability issues and two environmental priorities.
Key achievements and initiatives
Enhanced access to health and reduced environmental burden, with visualized non-financial initiatives.
Strengthened talent pipeline, succession planning, and introduced unified organizational values and health goals.
Board strengthened with independent directors and deeper, more strategic discussions.
Corporate value visualization and social impact
Non-financial value (roots) is foundational for future financial value (trunk and branches).
Social impact monetized: product impact far exceeds human capital, environmental, and access to health impacts.
Environmental negative impact reduced by 19% since FY2018 despite increased sales.
Access to health impact calculated by both reach and per capita effect, with ongoing expansion through healthcare system programs.
How does environmental impact reduction align with sales growth?
How does Astellas address Japan's drug discovery talent gap?
How does EPM ensure SMT cost optimization?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Astellas Pharma
- Double-digit growth and cost optimization drove higher forecasts and strong global sales.4503
Q3 20264 Feb 2026 - Record profit and revenue growth in FY2024, with strategic brands set to drive FY2025 gains.4503Q4 20253 Feb 2026
- Q1 revenue up 26.2% year-on-year, driven by XTANDI and strategic brands; profit and sales exceeded forecasts.4503Q1 20252 Feb 2026
- ASP3082 shows early efficacy and safety as a KRAS G12D degrader, with pipeline and collaboration expansion.4503Status Update20 Jan 2026
- Strong sales and profit growth led to raised forecasts, driven by XTANDI and strategic brands.4503Q2 202518 Jan 2026
- High-margin brands, clinical innovation, and cost discipline drive growth and margin targets.450344th Annual J.P. Morgan Healthcare Conference13 Jan 2026
- Core profit surged on XTANDI and new brands, but impairment losses led to a net loss.4503Q3 20259 Jan 2026
- Revenue and profit surged, driven by strategic brands, cost control, and pipeline progress.4503Q1 20266 Nov 2025
- Core operating profit surged 54.4% on 10.1% revenue growth and strong brand sales.4503Q2 20265 Nov 2025
Next Astellas Pharma earnings date
Q4 202624 Apr, 2026
Astellas Pharma
Next Astellas Pharma earnings date
Q4 202624 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage